BAKER BROS. ADVISORS LP

The estimated net worth of BAKER BROS. ADVISORS LP is at least $17,038 Million dollars as of 06/29/2022. BAKER BROS. ADVISORS LP is the Director, 10% Owner of ACADIA Pharmaceuticals Inc. BAKER BROS. ADVISORS LP owns over 38,536,853 shares of ACADIA Pharmaceuticals Inc stock worth over $547 Million . BAKER BROS. ADVISORS LP is the Director of Alexion Pharmaceuticals Inc. BAKER BROS. ADVISORS LP owns over 7,927,481 shares of Alexion Pharmaceuticals Inc stock worth over $1,446 Million . BAKER BROS. ADVISORS LP is the Director of Neoleukin Therapeutics Inc. BAKER BROS. ADVISORS LP owns over 3,503,951 shares of Neoleukin Therapeutics Inc stock worth over $3 Million . BAKER BROS. ADVISORS LP is the 10% Owner of BioCryst Pharmaceuticals Inc. BAKER BROS. ADVISORS LP owns over 9,441,849 shares of BioCryst Pharmaceuticals Inc stock worth over $102 Million . BAKER BROS. ADVISORS LP is the Director, 10% Owner of BeiGene Ltd. BAKER BROS. ADVISORS LP owns over 10,728,961 shares of BeiGene Ltd stock worth over $1,741 Million . BAKER BROS. ADVISORS LP is the 10% Owner of Bellicum Pharmaceuticals Inc. BAKER BROS. ADVISORS LP owns over 5,813 shares of Bellicum Pharmaceuticals Inc stock worth over $7,033.73. BAKER BROS. ADVISORS LP is the Director of Idera Pharmaceuticals Inc. BAKER BROS. ADVISORS LP owns over 2,319,324 shares of Idera Pharmaceuticals Inc stock worth over $1 Million . BAKER BROS. ADVISORS LP is the Director, 10% Owner of Incyte Corp. BAKER BROS. ADVISORS LP owns over 66,793,259 shares of Incyte Corp stock worth over $5,068 Million . BAKER BROS. ADVISORS LP is the 10% Owner of Mirati Therapeutics Inc. BAKER BROS. ADVISORS LP owns over 30,140 shares of Mirati Therapeutics Inc stock worth over $2 Million . BAKER BROS. ADVISORS LP is the of Intellia Therapeutics Inc. BAKER BROS. ADVISORS LP owns over 976,214 shares of Intellia Therapeutics Inc stock worth over $51 Million . BAKER BROS. ADVISORS LP is the Director, 10% Owner of Seagen Inc. BAKER BROS. ADVISORS LP owns over 42,970,781 shares of Seagen Inc stock worth over $7,694 Million . BAKER BROS. ADVISORS LP is the 10% Owner of Invitae Corp. BAKER BROS. ADVISORS LP owns over 7,553,553 shares of Invitae Corp stock worth over $19 Million . BAKER BROS. ADVISORS LP is the of Rhythm Pharmaceuticals Inc. BAKER BROS. ADVISORS LP owns over 1,878,242 shares of Rhythm Pharmaceuticals Inc stock worth over $8 Million . BAKER BROS. ADVISORS LP is the Director, 10% Owner of Kiniksa Pharmaceuticals Ltd. BAKER BROS. ADVISORS LP owns over 3,000,000 shares of Kiniksa Pharmaceuticals Ltd stock worth over $29 Million . BAKER BROS. ADVISORS LP is the Director, 10% Owner of Kodiak Sciences Inc. BAKER BROS. ADVISORS LP owns over 17,310,490 shares of Kodiak Sciences Inc stock worth over $137 Million . BAKER BROS. ADVISORS LP is the of HOOKIPA Pharma Inc. BAKER BROS. ADVISORS LP owns over 820,729 shares of HOOKIPA Pharma Inc stock worth over $1 Million . BAKER BROS. ADVISORS LP is the Director, 10% Owner of IGM Biosciences Inc. BAKER BROS. ADVISORS LP owns over 3,144,000 shares of IGM Biosciences Inc stock worth over $57 Million . BAKER BROS. ADVISORS LP is the Director, 10% Owner of Prelude Therapeutics Inc. BAKER BROS. ADVISORS LP owns over 9,247,763 shares of Prelude Therapeutics Inc stock worth over $47 Million . BAKER BROS. ADVISORS LP is the Director, 10% Owner of Talis Biomedical Corp. BAKER BROS. ADVISORS LP owns over 7,625,425 shares of Talis Biomedical Corp stock worth over $6 Million . BAKER BROS. ADVISORS LP is the Director, 10% Owner of TScan Therapeutics Inc. BAKER BROS. ADVISORS LP owns over 2,784,792 shares of TScan Therapeutics Inc stock worth over $8 Million . BAKER BROS. ADVISORS LP is the 10% Owner of Entrada Therapeutics Inc. BAKER BROS. ADVISORS LP owns over 4,865,819 shares of Entrada Therapeutics Inc stock worth over $62 Million .

BAKER BROS. ADVISORS LP mailing address: 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014

Insider Roles

Name Transaction Date Position
IGM Biosciences Inc 2022-03-12 director, 10 percent owner
Incyte Corp 2012-04-12 director, 10 percent owner
Kodiak Sciences Inc 2022-01-21 director, 10 percent owner
Prelude Therapeutics Inc 2020-09-24 director, 10 percent owner
Kiniksa Pharmaceuticals Ltd 2018-05-23 director, 10 percent owner
Atreca Inc 2019-06-19 10 percent owner
BeiGene Ltd 2016-02-02 director, 10 percent owner
ACADIA Pharmaceuticals Inc 2012-12-12 10 percent owner
Seagen Inc 2020-12-31 director, 10 percent owner
Alexion Pharmaceuticals Inc 2020-05-14 director
Zymeworks Inc 2020-03-16 director
Neoleukin Therapeutics Inc 2015-08-07 10 percent owner
Idera Pharmaceuticals Inc 2014-03-10 director
HOOKIPA Pharma Inc 2019-04-17 10 percent owner
Principia Biopharma Inc 2018-09-13 10 percent owner
Invitae Corp 2015-08-27 10 percent owner
Bellicum Pharmaceuticals Inc 2015-12-24 10 percent owner
Mirati Therapeutics Inc 2013-07-09 10 percent owner
Rhythm Pharmaceuticals Inc 2017-10-04 10 percent owner
BioCryst Pharmaceuticals Inc 2012-04-12 10 percent owner
Intellia Therapeutics Inc 2016-05-05 10 percent owner
XOMA Corp 2012-04-12 10 percent owner
XOMA Corp 2012-04-12 10 percent owner
Talis Biomedical Corp 2021-11-18 director, 10 percent owner
DBV Technologies SA 2021-01-01 director, 10 percent owner
Aeglea BioTherapeutics Inc 2021-02-23 director
Entrada Therapeutics Inc 2022-05-16 10 percent owner
TScan Therapeutics Inc 2022-05-10 director, 10 percent owner
EMBED
SAVE

BAKER BROS. ADVISORS LP trading performance

Average Relative Return

39.98%

Average relative return per transaction

Outperforming Transactions

62%

26 out of 42 outperforming transactions.
Each transaction is measured over a period and compared to .

BAKER BROS. ADVISORS LP trading performance analysis

1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -2.55 3.1 12.45 39.98 46.82 21.04
Relative Return to S&P 500(%) -4.63 -3.01 3.86 27.15 19.22 -16.28

Baker Bros. Advisors Lp trading transactions

Ticker Company Current Price Insider Name Insider Position Date Buy/Sell Insider Trading Shares Shares Change Price Cost Final Share Price Change Since Insider Trade (%) Filing Date Dividend Yield % PE Ratio Market Cap ($M)
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2022-06-06 Buy
572,349
3.42%
$7.77
$4,447,150
17,310,490
1.93%
2022-06-06
0
At Loss
407.37
TRDA
Entrada Therapeutics Inc
$12.94
BAKER BROS. ADVISORS LP
10% Owner
2022-06-06 Buy
40,947
0.85%
$6.37
$260,832
4,865,819
103.14%
2022-06-06
0
At Loss
356
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2022-05-27 Buy
350,406
2.14%
$6.75
$2,365,240
16,738,141
17.33%
2022-05-27
0
At Loss
407.37
TRDA
Entrada Therapeutics Inc
$12.94
BAKER BROS. ADVISORS LP
10% Owner
2022-05-24 Buy
48,509
1.02%
$5.82
$282,322
4,824,872
122.34%
2022-05-24
0
At Loss
356
TRDA
Entrada Therapeutics Inc
$12.94
BAKER BROS. ADVISORS LP
10% Owner
2022-05-18 Buy
71,944
1.53%
$5.99
$430,945
4,776,363
116.03%
2022-05-18
0
At Loss
356
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2022-05-18 Buy
456,690
2.87%
$5.91
$2,699,040
16,387,735
34.01%
2022-05-18
0
At Loss
407.37
TCRX
TScan Therapeutics Inc
$3.10
BAKER BROS. ADVISORS LP
Director, 10% Owner
2022-05-11 Buy
1,359,792
95.42%
$1.88
$2,556,410
2,784,792
64.89%
2022-05-12
0
At Loss
72.81
INCY
Incyte Corp
$75.89
BAKER BROS. ADVISORS LP
Director, 10% Owner
2022-03-10 Buy
389,080
0.59%
$72.24
$28,107,100
66,793,259
5.05%
2022-03-10
0
18.02
16,772.36
INCY
Incyte Corp
$75.89
BAKER BROS. ADVISORS LP
Director, 10% Owner
2022-02-22 Buy
525,804
1.46%
$67.96
$35,733,600
36,524,495
11.67%
2022-02-22
0
18.02
16,772.36
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2022-02-17 Buy
400,965
2.58%
$54.45
$21,832,500
15,931,045
-85.45%
2022-02-17
0
At Loss
407.37
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2022-01-31 Buy
347,665
2.29%
$52.02
$18,085,500
15,530,080
-84.78%
2022-01-31
0
At Loss
407.37
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2022-01-25 Buy
501,111
3.41%
$57.49
$28,808,900
15,182,415
-86.22%
2022-01-25
0
At Loss
407.37
INCY
Incyte Corp
$75.89
BAKER BROS. ADVISORS LP
Director, 10% Owner
2021-12-17 Buy
1,595,519
4.86%
$72.43
$115,563,000
34,399,479
4.78%
2021-12-17
0
18.02
16,772.36
SGEN
Seagen Inc
$179.06
BAKER BROS. ADVISORS LP
Director, 10% Owner
2021-12-01 Sell
394,895
-0.91%
$160.54
$63,396,400
42,970,781
11.54%
-
0
At Loss
33,476.16
TLIS
Talis Biomedical Corp
$0.82
BAKER BROS. ADVISORS LP
Director, 10% Owner
2021-11-18 Buy
50,000
0.66%
$4.37
$218,500
7,625,425
-81.21%
-
0
At Loss
21.93
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2021-09-30 Buy
86,932
0.60%
$95.83
$8,330,690
14,681,304
-91.74%
-
0
At Loss
407.37
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2021-09-16 Buy
31,838
0.22%
$94.39
$3,005,190
14,444,389
-91.61%
-
0
At Loss
407.37
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2021-09-07 Buy
57,501
0.40%
$93.31
$5,365,420
14,412,551
-91.51%
-
0
At Loss
407.37
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2021-08-19 Buy
114,396
0.80%
$87.50
$10,009,600
14,355,050
-90.95%
-
0
At Loss
407.37
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2021-08-13 Buy
102,773
0.73%
$87.19
$8,960,780
14,240,654
-90.92%
-
0
At Loss
407.37
TCRX
TScan Therapeutics Inc
$3.10
BAKER BROS. ADVISORS LP
Director
2021-07-20 Buy
1,425,000
0%
$15
$21,375,000
1,320,302
-79.33%
-
0
At Loss
72.81
TLIS
Talis Biomedical Corp
$0.82
BAKER BROS. ADVISORS LP
Director, 10% Owner
2021-02-17 Buy
6,250,000
829.17%
$16
$100,000,000
7,003,766
-94.87%
-
0
At Loss
21.93
BGNE
BeiGene Ltd
$162.29
BAKER BROS. ADVISORS LP
Director, 10% Owner
2021-01-04 Sell
121,154
-1.12%
$220.50
$26,714,500
10,728,961
-26.40%
-
0
At Loss
17,090.90
BGNE
BeiGene Ltd
$162.29
BAKER BROS. ADVISORS LP
Director, 10% Owner
2020-12-04 Sell
1,511,546
-12.25%
$220.50
$333,296,000
10,829,638
-26.40%
-
0
At Loss
17,090.90
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2020-11-20 Buy
1,527,777
13.63%
$108
$165,000,000
12,736,556
-92.67%
-
0
At Loss
407.37
PRLD
Prelude Therapeutics Inc
$5.18
BAKER BROS. ADVISORS LP
Director, 10% Owner
2020-09-29 Buy
1,578,947
20.59%
$19
$30,000,000
9,247,763
-72.74%
-
0
At Loss
241.82
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2020-09-25 Buy
48,125
0.39%
$56.65
$2,726,280
12,352,175
-86.02%
-
0
At Loss
407.37
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2020-09-24 Buy
203,047
1.68%
$51.71
$10,499,600
12,304,050
-84.68%
-
0
At Loss
407.37
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2020-09-08 Buy
322,979
2.74%
$47.43
$15,318,900
12,101,003
-83.30%
-
0
At Loss
407.37
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2020-08-21 Buy
203,486
1.76%
$48.23
$9,814,130
11,778,024
-83.58%
-
0
At Loss
407.37
NLTX
Neoleukin Therapeutics Inc
$1.02
BAKER BROS. ADVISORS LP
Director
2020-07-07 Buy
424,000
13.77%
$15.25
$6,466,000
3,503,951
-93.31%
-
0
At Loss
42.19
SGEN
Seagen Inc
$179.06
BAKER BROS. ADVISORS LP
Director, 10% Owner
2020-05-15 Sell
1,750,000
-1.98%
$160
$280,000,000
86,760,740
11.91%
-
0
At Loss
33,476.16
SGEN
Seagen Inc
$179.06
BAKER BROS. ADVISORS LP
Director, 10% Owner
2020-05-08 Sell
1,058,316
-2.29%
$161.85
$171,288,000
45,072,881
10.63%
-
0
At Loss
33,476.16
ACAD
ACADIA Pharmaceuticals Inc
$14.22
BAKER BROS. ADVISORS LP
Director, 10% Owner
2020-03-18 Buy
1,050,000
2.80%
$32.05
$33,652,500
38,536,853
-55.63%
-
0
At Loss
2,339.77
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2020-03-18 Buy
150,000
1.31%
$39.29
$5,893,500
11,574,538
-79.84%
-
0
At Loss
407.37
ALXN
Alexion Pharmaceuticals Inc
$182.50
BAKER BROS. ADVISORS LP
Director
2020-03-18 Buy
81,379
1.03%
$82.01
$6,673,890
8,002,119
122.53%
-
0
59.16
40,336.01
ALXN
Alexion Pharmaceuticals Inc
$182.50
BAKER BROS. ADVISORS LP
Director
2020-03-18 Buy
418,621
5.58%
$78.33
$32,790,600
7,927,481
132.99%
-
0
59.16
40,336.01
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2020-02-26 Buy
377,249
3.41%
$57.87
$21,831,400
11,424,538
-86.31%
-
0
At Loss
407.37
NLTX
Neoleukin Therapeutics Inc
$1.02
BAKER BROS. ADVISORS LP
Director
2019-12-20 Buy
3,017,542
23.28%
$8.40
$25,347,400
15,982,255
-87.86%
-
0
At Loss
42.19
KOD
Kodiak Sciences Inc
$7.92
BAKER BROS. ADVISORS LP
Director, 10% Owner
2019-12-06 Buy
1,902,173
20.80%
$46
$87,500,000
11,047,289
-82.78%
-
0
At Loss
407.37
Total 121
  • 1
  • 2
  • 3
  • 4

BAKER BROS. ADVISORS LP personal network

Name Position Linked company